CLASSIFICATION: GROWTH HORMONE ANALOG
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 KIT [10 X 2 ML VIALS] x 10 IU
ACTIVE HALF-LIFE: 2.5-3 DAYS
DOSAGE: MEN 4-10 IU/DAY
MANUFACTURER: KALPA PHARMACEUTICALS
Kalpa Pharmaceuticals Kalpatropin HGH 100 IU is a recombinant human growth hormone (somatropin) produced via advanced DNA technology, identical to the endogenous 191-amino acid polypeptide. Each kit contains 10 individually sealed 2 mL vials, each containing 10 IU of lyophilized somatropin, for a total of 100 IU per kit.
Kalpatropin HGH is designed for research applications involving growth hormone pathways, including studies on protein synthesis, lipolysis, cellular regeneration, and metabolic regulation. For researchers investigating anabolic processes or recovery mechanisms, this compound offers direct GH replacement. Explore similar research compounds like Tesamorelin 5 mg or Ipamorelin 5 mg.
Unlike GH secretagogues that stimulate endogenous release, Kalpatropin HGH provides direct exogenous somatropin identical to the human form. This allows researchers to bypass upstream signaling pathways and study the direct effects of GH on target tissues. The 100 IU kit format provides flexibility for both acute and extended research protocols.
For performance-focused research, Kalpatropin HGH is often studied for its effects on lean body mass, recovery, and metabolic parameters. The 10 IU per vial format allows for precise dosing in multi-week research models. Researchers may also compare Kalpatropin HGH with Kalpatropin HGH 200 IU for larger-scale studies.
Kalpa Pharmaceuticals Kalpatropin HGH 100 IU is intended for laboratory research only. Not for human consumption or clinical use.
External research on recombinant human growth hormone mechanisms can be explored via PubMed for peer-reviewed studies.
For laboratory research use only. Not for human consumption. Reconstitution and handling must be performed by qualified personnel using sterile techniques.
Reconstitution with 1 mL yields a concentration of 10 IU/mL. For precise dosing, researchers should calculate based on desired IU per injection volume using insulin-grade syringes.
In animal models, somatropin is often administered at dosages ranging from 2-6 IU per day, typically divided into daily subcutaneous injections. Due to its short half-life, once-daily administration is standard in prolonged studies.
Kalpatropin HGH is often studied in isolation for direct GH effects. However, some protocols combine it with anabolic agents to evaluate synergistic effects on protein synthesis and body composition. For comprehensive research, explore our range of Kalpatropin HGH 200 IU for larger-scale studies.
Note: Dosages mentioned are for research purposes only. Individual response varies in animal models. Always follow institutional animal care guidelines when conducting in vivo research.
Third-party analytical testing (COA) for Kalpa Pharmaceuticals Kalpatropin HGH 100 IU is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.
This product is supplied through the official Kalpa Pharmaceuticals distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Store Kalpa Pharmaceuticals Kalpatropin HGH 100 IU lyophilized powder in a cool, dry place away from direct light and moisture. Prior to reconstitution, the unopened vials should be kept refrigerated (2-8°C) for long-term storage. Do not freeze the lyophilized powder, as this may damage the peptide structure.
After reconstitution with bacteriostatic water, the solution must be stored at 2-8°C (refrigerator) and used within 30 days to maintain peptide integrity. Do not shake the reconstituted solution. Avoid repeated freeze-thaw cycles. Do not use if the solution appears cloudy or contains particulates, or if the vial seal is compromised.
Keep out of reach of children and unauthorized personnel. Follow standard laboratory safety protocols when handling growth hormone preparations.
Proper storage conditions help maintain research-grade purity and consistent performance across the product's shelf life.
Kalpatropin HGH (somatropin) is studied for direct growth hormone effects on protein synthesis, lipolysis, cellular regeneration, and metabolic regulation in animal models. It is recombinant human GH identical to endogenous 191-amino acid GH.
Add 1-2 mL of bacteriostatic water to each 10 IU vial, swirling gently until fully dissolved. Do not shake. Reconstitution with 1 mL yields a concentration of 10 IU/mL.
In animal studies, dosages often range from 2-6 IU per day, administered once daily subcutaneously due to the 2-3 hour half-life. Dosing should be scaled appropriately for the research model.
Kalpatropin HGH provides direct exogenous somatropin identical to endogenous GH, bypassing upstream signaling pathways. GH secretagogues (like Ipamorelin or Tesamorelin) stimulate endogenous GH release through the hypothalamus and pituitary.
Third-party COA testing is currently pending. Kalpa Pharmaceuticals is committed to publishing batch-specific lab reports as soon as analytical testing is completed and verified.
Please log in to write KALPATROPIN HGH 100 IU review.
CLASSIFICATION: GROWTH HORMONE ANALOG
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 KIT x 2 ML VIALS x 10 IU (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: 2.5-3 DAYS
DOSAGE: MEN 4-10 IU/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS